Harmaline induces apoptosis and inhibits migration in A2780 ovarian cancer cells in vitro
Physiological Reports · 2024
DOI: 10.14814/phy2.15984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2024. Verfasst von Seyed Ali Shariat Razavi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Ovarian Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mashhad University of Medical Sciences (MUMS).
Abstract (Originalsprache)
Ovarian cancer is one of the most prevalent malignancies in women. Harmaline is reported to have powerful anticancer properties. We aimed to investigate the apoptotic and antimetastatic properties of harmaline in A2780 ovarian cancer cells. Cell viability, apoptosis, migration, and invasion were investigated in cells treated with harmaline. Reactive oxygen species (ROS) production, mRNA expression of apoptosis‐associated genes, MMP‐2, and MMP‐9 were measured. Harmaline attenuated the viability of A2780 ovarian cancer cells in a dose‐ and time‐dependent way. Furthermore, compared to NIH/3T3 mouse normal cell line (IC50 = 417 μM), the malignant A2080 cells were more sensitive to harmaline (IC50 = 300 μM after 24 h). Harmaline increased the production of ROS, raised the mRNA expression of p53 and the Bax/Bcl2 ratio. Harmaline also increased the proportion of cells in the late apoptotic and necrotic phases. MMP‐2 and MMP‐9's mRNA expression, gelatinase activity, and migration of A2780 cells also decreased by harmaline. These findings suggest that harmaline may have the potential to be a therapeutic drug for ovarian cancer by triggering apoptosis and suppressing invasion and migration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Student Research Committee, Islamic Azad University Mashhad Branch, Mashhad, Iran.
- Department of Medicine, Mashhad Medical Sciences Branch, Islamic Azad University, Mashhad, Iran.
- Department of Laboratory Sciences, School of Allied Medical Sciences, Arak University of Medical Sciences, Arak, Iran.
- Division of Medical Education, Brighton and Sussex Medical School, Falmer, Brighton, Sussex, UK.
- Clinical Research Development Unit, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Afsane Bahrami
Förderung
- Mashhad University of Medical Sciences (MUMS)
Zitieren
APA
Shariat Razavi, S. A., Taghdisi Khaboushan, M., Jafari, R., Shahini, A., Ferns, G. A., & Bahrami, A. (2024). Harmaline induces apoptosis and inhibits migration in A2780 ovarian cancer cells in vitro. Physiological Reports. https://doi.org/10.14814/phy2.15984
Vancouver
Shariat Razavi SA, Taghdisi Khaboushan M, Jafari R, Shahini A, Ferns GA, Bahrami A. Harmaline induces apoptosis and inhibits migration in A2780 ovarian cancer cells in vitro. Physiological Reports. 2024. doi:10.14814/phy2.15984
BibTeX
@article{ShariatRazavi2024,
author = {Shariat Razavi, Seyed Ali and Taghdisi Khaboushan, Masoumeh and Jafari, Raha and Shahini, Arshia and Ferns, Gordon A and Bahrami, Afsane},
title = {Harmaline induces apoptosis and inhibits migration in A2780 ovarian cancer cells in vitro},
journal = {Physiological Reports},
year = {2024},
doi = {10.14814/phy2.15984}
}
EUVIMED